4-(methylsulfonyl)-Biphenyl-2-carboxylic acid → HCID 59853649, Verbindung
Reaktionsgleichung
[CH3:1][N:2]([CH3:15])[C:3]1[N:8]=[C:7]([N:9]2[CH2:14][CH2:13][NH:12][CH2:11][CH2:10]2)[N:6]=[CH:5][N:4]=1.[CH3:16][S:17]([C:20]1[CH:21]=[C:22]([C:32](O)=[O:33])[C:23]([C:26]2[CH:31]=[CH:30][CH:29]=[CH:28][CH:27]=2)=[CH:24][CH:25]=1)(=[O:19])=[O:18]>>[CH3:1][N:2]([CH3:15])[C:3]1[N:4]=[CH:5][N:6]=[C:7]([N:9]2[CH2:14][CH2:13][N:12]([C:32]([C:22]3[CH:21]=[C:20]([S:17]([CH3:16])(=[O:19])=[O:18])[CH:25]=[CH:24][C:23]=3[C:26]3[CH:31]=[CH:30][CH:29]=[CH:28][CH:27]=3)=[O:33])[CH2:11][CH2:10]2)[N:8]=1Komponenten
3
Versuchsvorschrift
The title compound was prepared according to the procedure E described for Example 9 from Dimethyl-(4-piperazin-1-yl-[1,3,5]triazin-2-yl)-amine (Example X) and 4-Methanesulfonyl-biphenyl-2-carboxylic acid (Example V). MS (ISP): 467.4 MH+.
Quellen und Nachweise
- ORD-Eintrag
- ord-7225af28f7e64f678116e9dc4186577a
- Quelldatensatz
- uspto-grants-2008_12
- Patentnummer